Hai-ying Y. Zeng
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancer.
Journal: Clinical and translational medicine
Published: October 13, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors.
Journal: Journal of translational medicine
Published: April 14, 2024
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma.
Journal: International immunopharmacology
Published: February 10, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 08, 2023
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion.
Journal: Hepatology international
Published: August 17, 2022
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Journal: Nature communications
Published: August 08, 2022
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
Journal: Journal of hematology & oncology
Published: August 12, 2021
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Journal: Frontiers in immunology
Published: May 05, 2021
Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically.
Journal: Clinical and translational medicine
Published: July 23, 2020
Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma.
Journal: Journal of Cancer
Published: May 04, 2019
Last Updated: 09/26/2026